Park Dental Partners, Inc. (PARK)
NASDAQ:PARK
Want to see PARK full AI Analyst Report?
PARK Stock Chart & Stats
$17.33
--
Market closed
$17.33
--
Day’s Range― - ―
52-Week Range$9.53 - $22.62
Previous CloseN/A
VolumeN/A
Average Volume (3M)96.30K
Market Cap
$93.06M
Enterprise Value$73.06M
Total Cash (Recent Filing)$24.37M
Total Debt (Recent Filing)$59.75M
Price to Earnings (P/E)―
Beta0.05
Next Earnings
Mar 03, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding4,515,054
10 Day Avg. Volume61,908
30 Day Avg. Volume96,297
Financial Highlights & Ratios
PEG Ratio0.69
Price to Book (P/B)1.32
Price to Sales (P/S)0.12
P/FCF Ratio2.79
Enterprise Value/Market Cap0.79
Enterprise Value/Revenue0.30
Enterprise Value/Gross Profit2.38
Enterprise Value/Ebitda16.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)1.09
Revenue Forecast (FY)$256.60M
Bulls Say, Bears Say
Bulls Say
Consistent Cash GenerationPark Dental reports positive operating cash flow and free cash flow across annual periods, improving into 2024. Durable cash generation funds operations, supports integration of acquisitions, and provides internal capital for reinvestment, lowering reliance on external funding despite moderate coverage vs. debt.
High Patient Retention And Growing Provider BaseA patient retention rate above 90% and an expanding base of 221 doctors underpin recurring demand and utilization. Combined with 4.1% same-practice growth and mid-single-digit revenue expansion, this creates a durable revenue foundation and scalable capacity for organic growth over the medium term.
Financing Amendment Boosts Liquidity For GrowthThe credit facility amendment extends the revolver maturity and aligns covenants with public-company reporting, preserving access to a $15M revolver and term financing. This structural liquidity improvement supports M&A activity and working-capital needs, reducing near-term refinancing risk while enabling strategic growth.
Bears Say
Historical Negative Equity / High LeverageHistoric negative equity and elevated leverage materially weaken the balance sheet and complicate leverage metrics. The large 2025 step-change reduces trend comparability, increases covenant and creditor sensitivity, and constrains financial flexibility to absorb shocks or fund opportunistic investments without taxable or dilutive financing.
Persistent GAAP Losses And Weak MarginsDespite revenue growth, GAAP profitability remains negative across reported periods with modest gross margins. Reliance on adjusted EBITDA obscures persistent operating and non-cash charges; ongoing GAAP losses limit retained earnings, reduce internal capital accumulation, and place greater reliance on cash generation and external financing for growth.
Elevated Share-based Comp And Public-company CostsAccelerated IPO-related share-based compensation and higher public-company expenses materially pressure GAAP margins near term. Concentration of share-based comp with doctor shareholders creates recurring non-cash expense and share-count dilution that erodes GAAP EPS comparability and may persist through vesting schedules, affecting reported profitability.
Park Dental Partners, Inc. News
PARK FAQ
What was Park Dental Partners, Inc.’s price range in the past 12 months?
Park Dental Partners, Inc. lowest stock price was $9.53 and its highest was $22.62 in the past 12 months.
What is Park Dental Partners, Inc.’s market cap?
Park Dental Partners, Inc.’s market cap is $93.06M.
When is Park Dental Partners, Inc.’s upcoming earnings report date?
Park Dental Partners, Inc.’s upcoming earnings report date is Mar 03, 2027 which is in 271 days.
How were Park Dental Partners, Inc.’s earnings last quarter?
Park Dental Partners, Inc. released its earnings results on May 13, 2026. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.2 by $0.24.
Is Park Dental Partners, Inc. overvalued?
According to Wall Street analysts Park Dental Partners, Inc.’s price is currently Overvalued.
Does Park Dental Partners, Inc. pay dividends?
Park Dental Partners, Inc. does not currently pay dividends.
What is Park Dental Partners, Inc.’s EPS estimate?
Park Dental Partners, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Park Dental Partners, Inc. have?
Park Dental Partners, Inc. has 4,515,054 shares outstanding.
What happened to Park Dental Partners, Inc.’s price movement after its last earnings report?
Park Dental Partners, Inc. reported an EPS of $0.44 in its last earnings report, beating expectations of $0.2. Following the earnings report the stock price went down -1.749%.
Which hedge fund is a major shareholder of Park Dental Partners, Inc.?
Currently, no hedge funds are holding shares in PARK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Park Dental Partners, Inc. Stock Smart Score
Company Description
Park Dental Partners, Inc.
Park Dental Partners, Inc. operates as a dental resource organization that offers business support services to dentists throughout Minnesota and Wisconsin. The company's services include provision of clinical team members, administrative personnel, facilities and equipment to affiliated general and multi-specialty dental practitioners. Its network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics. Park Dental Partners, Inc. was founded in 1972 and is based in Roseville, Minnesota.
PARK Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed solid operational momentum with mid-single-digit revenue growth (6.2% YoY), healthy same-practice growth (4.1%), positive adjusted EBITDA and cash flow, a strong patient retention rate (>90%), and a robust M&A pipeline and balance sheet. Near-term GAAP profitability is pressured by elevated share-based compensation (IPO vesting acceleration), higher public company costs, and a larger share count that depresses GAAP EPS versus prior year. Management maintained full-year guidance and emphasized continued investments in capacity and disciplined M&A. Overall, positive operational and liquidity indicators outweigh the near-term GAAP expense headwinds and seasonality risks.View all PARK earnings summariesPARK Stock 12 Month Forecast
Average Price Target
―Labcorp Holdings
―
Envista Holdings
―
American Well
―
DocGo
―
Concentra Group Holdings Parent, Inc.
―
Ownership Overview
―
Insiders
5.97% Mutual Funds
12.56% Other Institutional Investors
80.84% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---